These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30788758)

  • 21. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging.
    Doukky R; Nigatu A; Khan R; Anokwute C; Fughhi I; Ayoub A; Iskander F; Iskander M; Kola S; Sahyouni M; Karavolos K; Hota BN; Gomez J
    J Nucl Cardiol; 2020 Oct; 27(5):1521-1532. PubMed ID: 30132187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial creep and cardiorespiratory motion correction improves diagnostic accuracy of Rubidium-82 cardiac positron emission tomography.
    Lassen ML; Rasmussen T; Byrne C; Holmvang L; Kjaer A; Hasbak P
    J Nucl Cardiol; 2023 Dec; 30(6):2289-2300. PubMed ID: 37624562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of myocardial blood flow with 82Rb positron emission tomography: clinical validation with 15O-water.
    Prior JO; Allenbach G; Valenta I; Kosinski M; Burger C; Verdun FR; Bischof Delaloye A; Kaufmann PA
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):1037-47. PubMed ID: 22398957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Displacement During
    Vleeming EJ; Lazarenko SV; van der Zant FM; Pan XB; Declerck JM; Wondergem M; Knol RJJ
    J Nucl Med Technol; 2018 Jun; 46(2):114-122. PubMed ID: 29273695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of temporal sampling protocols on myocardial blood flow measurements using Rubidium-82 PET.
    Koenders SS; van Dijk JD; Jager PL; Mouden M; Tegelaar AG; Slump CH; van Dalen JA
    J Nucl Cardiol; 2022 Aug; 29(4):1729-1741. PubMed ID: 33655444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consistent tracer administration profile improves test-retest repeatability of myocardial blood flow quantification with
    Klein R; Ocneanu A; Renaud JM; Ziadi MC; Beanlands RSB; deKemp RA
    J Nucl Cardiol; 2018 Jun; 25(3):929-941. PubMed ID: 27804067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease: a preliminary study.
    Qayyum AA; Hasbak P; Larsson HBW; Christensen TE; Ghotbi AA; Mathiasen AB; Vejlstrup NG; Kjaer A; Kastrup J
    Eur J Radiol; 2014 Jul; 83(7):1120-1128. PubMed ID: 24815746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive and balanced reduction of myocardial blood flow in patients with suspected obstructive coronary artery disease: 15O-water PET study.
    Maaniitty T; Stenström I; Saraste A; Knuuti J
    Int J Cardiol; 2021 Sep; 338():1-7. PubMed ID: 34144073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
    Kitkungvan D; Bui L; Johnson NP; Patel MB; Roby AE; Vejpongsa P; Babar AK; Madjid M; Nacimbene A; Kumar S; DeGolovine A; Gould KL
    Eur Heart J Cardiovasc Imaging; 2019 Jul; 20(7):751-762. PubMed ID: 31056681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual Activity Correction in Quantitative Myocardial Perfusion
    Markousis-Mavrogenis G; Juárez-Orozco LE; Alexanderson E
    Hellenic J Cardiol; 2017; 58(3):245-249. PubMed ID: 28137454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole.
    Cullom SJ; Case JA; Courter SA; McGhie AI; Bateman TM
    J Nucl Cardiol; 2013 Feb; 20(1):76-83. PubMed ID: 23188625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of SiPM PET in myocardial perfusion imaging using Rubidium-82.
    Koenders SS; van Dalen JA; Jager PL; Knollema S; Timmer JR; Mouden M; Slump CH; van Dijk JD
    J Nucl Cardiol; 2022 Feb; 29(1):204-212. PubMed ID: 32410059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.
    Brana Q; Thibault F; Courtehoux M; Metrard G; Ribeiro MJ; Angoulvant D; Bailly M
    J Nucl Cardiol; 2022 Feb; 29(1):113-122. PubMed ID: 32651801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET.
    Yoshinaga K; Katoh C; Manabe O; Klein R; Naya M; Sakakibara M; Yamada S; Dekemp RA; Tsutsui H; Tamaki N
    Circ J; 2011; 75(11):2628-34. PubMed ID: 21873801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated Motion Correction for Myocardial Blood Flow Measurements and Diagnostic Performance of
    Kuronuma K; Wei CC; Singh A; Lemley M; Hayes SW; Otaki Y; Hyun MC; Van Kriekinge SD; Kavanagh P; Huang C; Han D; Dey D; Berman DS; Slomka PJ
    J Nucl Med; 2024 Jan; 65(1):139-146. PubMed ID: 38050106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
    Partington SL; Lanka V; Hainer J; Blankstein R; Skali H; Forman DE; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2012 Oct; 19(5):970-8. PubMed ID: 22565239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of transient ischemic dilation (TID) ratio in gated SPECT myocardial perfusion imaging (MPI) using regadenoson, a new agent for pharmacologic stress testing.
    Katz JS; Ruisi M; Giedd KN; Rachko M
    J Nucl Cardiol; 2012 Aug; 19(4):727-34. PubMed ID: 22527801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison and prognostic validation of multiple methods of quantification of myocardial blood flow with 82Rb PET.
    Murthy VL; Lee BC; Sitek A; Naya M; Moody J; Polavarapu V; Ficaro EP; Di Carli MF
    J Nucl Med; 2014 Dec; 55(12):1952-8. PubMed ID: 25429160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience with regadenoson stress positron emission tomography in patients with left bundle branch block: Low prevalence of septal defects and high accuracy for obstructive coronary artery disease.
    Meredith D; Cremer PC; Harb SC; Xu B; Mentias A; Jaber WA
    J Nucl Cardiol; 2021 Apr; 28(2):536-542. PubMed ID: 30877551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.